Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Johnson & Johnson : J&J in $4 Billion Settlement Talks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/12/2013 | 11:16pm CEST

Johnson & Johnson (JNJ) has agreed to pay $4 billion to settle more than 7,500 lawsuits over the company's recalled hip-implant products, Bloomberg News reported Tuesday, citing three people familiar with the agreement.

The settlement will be announced next week, Bloomberg reported.

Full story at: www.bloomberg.com/news/2013-11-12/j-j-said-to-reach-4-billion-deal-to-settle-hip- awsuits.html

Write to [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
06/24 JOHNSON & JOHNSON : American Dental Hygienists' Association Honors Dental Hygien..
06/24 DXB ENTERTAINMENTS : DDB Dubai appoints Iris Minnema as MD
06/23 JOHNSON & JOHNSON : State investigates drug makers
06/23 JOHNSON & JOHNSON : Donald Trump picks Woody Johnson to be US ambassador to Brit..
06/22 JOHNSON & JOHNSON : Innovation Announces New Collaborations Advancing Ground-Bre..
06/22 BRISTOL MYERS SQUIBB : Supreme Court ruling could make it harder to file class-a..
06/22 MARKETS RIGHT NOW : After early stumble, stocks drift higher
06/22 JOHNSON & JOHNSON : Completes Acquisition of Actelion, a Leader in Pulmonary Hyp..
06/22 JOHNSON & JOHNSON : Releases 2016 Health for Humanity Report
06/22 JOHNSON & JOHNSON : Missouri AG files suit against three opioid manufacturers
More news
Sector news : Pharmaceuticals - NEC
06/23DJSAMSUNG ELECTRONICS : Makes Play for Drug Market With Version of Humira -- Updat..
06/23DJSAMSUNG ELECTRONICS : Makes Big Play in Drug Market With Cheaper Version of Bloc..
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/23 China's ICBC says checks of loans to big acquirers are routine
06/22 GSK'S NEW CEO AIMS TO DIVEST SPORTS : sources
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06/23 Look Out Below - Tax Issues Could Catch ALIOY Holders By Surprise
06/22 I Bought The 7.65% Yield But Only Fools Are Buying The 8.16% Yield
06/22 8.76% Dividend Yield Whoops Brothers 8.61%
06/22 Only Bristol Bucks Big Pharma's Drive For External Reliance
06/22 Market Is Divided Between Growth And Value - Cramer's Mad Money (6/21/17)
Advertisement
Financials ($)
Sales 2017 75 604 M
EBIT 2017 23 480 M
Net income 2017 17 895 M
Debt 2017 8 106 M
Yield 2017 2,46%
P/E ratio 2017 20,81
P/E ratio 2018 18,69
EV / Sales 2017 4,97x
EV / Sales 2018 4,73x
Capitalization 367 520 M
More Financials
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 132 $
Spread / Average Target -3,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer & Executive VP
Charles O. Prince Independent Director
William David Perez Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON18.42%367 520
NOVARTIS12.96%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
SANOFI14.27%123 860
More Results